Detailed View
WST - West Pharmaceutical Services, I
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
24,354,234,368
Adj EBIT (TTM)
713,000,000
Enterprise Value
24,125,734,368
Last Price
346.06
Earnings Yield
2.96%
Return on Capital
21.47%
Capital
3,320,800,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 872,300,000 | 179,100,000 |
| 2026-03-31 | 10-Q | 2026 | 844,900,000 | 177,100,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 805,000,000 | 156,600,000 |
| 2025-09-30 | 10-Q | 2025 | 804,600,000 | 167,600,000 |
| 2025-06-30 | 10-Q | 2025 | 766,500,000 | 153,700,000 |
| 2025-03-31 | 10-Q | 2025 | 698,000,000 | 107,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 748,800,000 | 159,600,000 |
| 2024-09-30 | 10-Q | 2024 | 746,900,000 | 161,300,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.